GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Marketable Securities

Qingdao Vland Biotech Co (SHSE:603739) Marketable Securities : ¥326 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Qingdao Vland Biotech Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥326 Mil.

Qingdao Vland Biotech Co's annual Marketable Securities increased from Dec. 2021 (¥170 Mil) to Dec. 2022 (¥212 Mil) and increased from Dec. 2022 (¥212 Mil) to Dec. 2023 (¥292 Mil).


Qingdao Vland Biotech Co Marketable Securities Historical Data

The historical data trend for Qingdao Vland Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Marketable Securities Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.90 97.46 170.43 212.02 292.05

Qingdao Vland Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 255.11 257.68 319.16 292.05 326.32

Qingdao Vland Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Qingdao Vland Biotech Co  (SHSE:603739) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Qingdao Vland Biotech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Vland Biotech Co (SHSE:603739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Chen Gang Director
Jia De Qiang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines